MedPath

HS-10383

Generic Name
HS-10383

A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)

Phase 2
Not yet recruiting
Conditions
Cough
Interventions
Drug: HS-10383 Placebo
First Posted Date
2024-02-07
Last Posted Date
2024-03-04
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
276
Registration Number
NCT06246565

A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383

Phase 1
Recruiting
Conditions
Cough
Interventions
Drug: HS-10383 Placebo
First Posted Date
2023-10-23
Last Posted Date
2023-10-23
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
48
Registration Number
NCT06092983
Locations
🇨🇳

Shandong provincial qianfoshan hospital, Jinan, Shandong, China

First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383

Phase 1
Conditions
Cough
Interventions
Drug: HS-10383 Placebo
First Posted Date
2022-06-23
Last Posted Date
2022-07-01
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
32
Registration Number
NCT05429723
Locations
🇨🇳

Shandong provincial qianfoshan hospital, Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath